Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Generative AI-Assisted Discovery of HPK1 Inhibitors.
Journal: Journal of medicinal chemistry
Published: July 21, 2026
Rapid Peak Cilta-cel Expansion is Associated with Delayed Neurotoxicity in Multiple Myeloma.
Journal: Blood
Published: December 15, 2025
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome.
Journal: Journal of medicinal chemistry
Published: September 03, 2025
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma.
Journal: Neuro-oncology advances
Published: April 08, 2025
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor.
Journal: Journal of medicinal chemistry
Published: February 10, 2025
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
Journal: Journal of neuro-oncology
Published: January 08, 2021
Structural Basis for Targeting the Folded P-Loop Conformation of c-MET.
Journal: ACS medicinal chemistry letters
Published: July 13, 2020
Discovery of a Novel Small-Molecule Modulator of C-X-C Chemokine Receptor Type 7 as a Treatment for Cardiac Fibrosis.
Journal: Journal of medicinal chemistry
Published: April 10, 2018
Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1).
Journal: ACS medicinal chemistry letters
Published: January 10, 2018
Identification of Morpholino-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-ones as Nonsteroidal Mineralocorticoid Antagonists.
Journal: Journal of medicinal chemistry
Published: January 05, 2018
Superconducting and normal-state anisotropy of the doped topological insulator Sr0.1Bi2Se3.
Journal: Scientific reports
Published: December 11, 2017
Chiral Sulfoxide-Induced Single Turn Peptide α-Helicity.
Journal: Scientific reports
Published: May 18, 2016
Last Updated: 09/26/2026